All posts by

Researchers at the 3rd International Symposium on Lung-Sparing Therapies for Mesothelioma Present Promising Treatments for Extending Survival and Improving Quality of Life for Victims

By Patricia Kirk

An international roster of distinguished Mesothelioma (MPM) experts came together on Saturday, May 18, in Santa Monica, Calif., to discuss their latest research on lung-sparing therapies for MPM, a rare form of cancer that usually results from exposure to asbestos and commonly affects the pleura, or outer lining of the lungs, and chest wall.

Hosted by the Pacific Heart, Lung and Blood Institute and UCLA, the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma focused on research aimed at preserving vital lung function in mesothelioma patients. Presentations included the latest surgical techniques for removal of cancerous tumors and adjunct techniques and therapies to kill residual cancer cells following surgery and stop tumor growth.

Read More ⇒

Disclaimer

You’re on this website because you’re searching for information about pleural mesothelioma from a doctor and not from lawyers. We are an independent site not affiliated with any law firm, nor do we give advice on law firms. On this site, you can learn about the latest treatment and research from Dr. Robert B. Cameron, a board certified surgeon on the forefront of mesothelioma for over 25 years and Scientific Advisor of the Pacific Meso Center. He is the innovator of the lung-sparing surgical procedure that has become the standard of care.

While this website contains general information about mesothelioma, treatment and research, this information is not advice and should not be treated as such. You should always consult your own physician for medical advice. The Pacific Meso Center (PMC) is a division of the Pacific Heart, Lung & Blood Institute, a 501(c)(3) non-profit medical research institute.